• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer
  • Advertise
  • Subscribe

MassDevice

The Medical Device Business Journal — Medical Device News & Articles | MassDevice

  • Latest News
  • Technologies
    • Artificial Intelligence (AI)
    • Cardiovascular
    • Orthopedics
    • Neurological
    • Diabetes
    • Surgical Robotics
  • Business & Finance
    • Wall Street Beat
    • Earnings Reports
    • Funding Roundup
    • Mergers & Acquisitions
    • Initial Public Offering (IPO)
    • Legal News
    • Personnel Moves
    • Medtech 100 Stock Index
  • Regulatory & Compliance
    • Food & Drug Administration (FDA)
    • Recalls
    • 510(k)
    • Pre-Market Approval (PMA)
    • MDSAP
    • Clinical Trials
  • Special Content
    • Special Reports
    • In-Depth Coverage
    • DeviceTalks
  • Podcasts
    • MassDevice Fast Five
    • DeviceTalks Weekly
    • OEM Talks
      • AbbottTalks
      • Boston ScientificTalks
      • DeviceTalks AI
      • IntuitiveTalks
      • MedtechWOMEN Talks
      • MedtronicTalks
      • Neuro Innovation Talks
      • Ortho Innovation Talks
      • Structural Heart Talks
      • StrykerTalks
  • Resources
    • About MassDevice
    • DeviceTalks
    • Newsletter Signup
    • Leadership in Medtech
    • Manufacturers & Suppliers Search
    • MedTech100 Index
    • Videos
    • Webinars
    • Whitepapers
    • Voices
Home » Access Vascular raises $6m for HydroPICC device

Access Vascular raises $6m for HydroPICC device

September 26, 2019 By Brad Perriello

Access VascularAccess Vascular said today that it raised $6 million from new and existing investors for the HyrdoPICC device it developed, earmarking the proceeds for the launch of.

HydroPICC, a peripherally inserted central catheter, is made of a proprietary material that’s designed to inhibit the formation of blood clots. It won 510(k) clearance from the FDA in February 2018.

Bedford, Mass.-based Access Vascular said it plans to use the proceeds for launching a next-generation product, a post-market registry study and R&D. Founder & CEO Jim Biggins told MassDevice.com that the bulk of the round will be used to generate early-use clinical data and to fund further commercialization. Longer-term, the company is eyeing unmet needs in the vascular access space, Biggins told us.

“We had great feedback from our early clinical supporters in January, when we did the first couple of patients. That information was used to make some changes to the kit itself,” he said. “We’ll roll out some smaller clinical studies in the very beginning part of next year.

“In the PICC space, we think it’s much more important to show the attributes of thrombosis reduction or near elimination to be the standard of care. And that’s sort of where we’re going to put our funds to use,” he told us. “We think it’s important to be that clinical think tank for all of these clinicians, to have that data and offer it not necessarily a service, but as the expert on venous access devices.”

Access Vascular also plans to seek FDA clearance for a second product next year and has its eye on potential targets, including catheters with active bloodstream infection-fighting properties or that could allow insertion through difficult or stenosed vessels.

“We’re looking to address other, very large unmet needs across the entire sweep of venous access products,” Biggins said. “They can all benefit from our type of material.”

On the sales side, Access is looking to build on a breakthrough technology contract with group purchasing organization Premier.

“We signed a great agreement with Premier and plan to leverage that to start our commercial use,” he explained. “We’re going to build that sales team to help penetrate the markets that we’re in.

“It’s a $3.5 billion venous access market with lots of global international players that haven’t innovated. Eighty percent to 90% of all patients entering the hospital system require some sort of intravenous access. That’s a huge number. From our estimates, about 30% of all those patients are going to have some sort of complication,” Biggins said.

The round was led by an international family office that Biggins declined to identify, saying only that the fund “has sort of found a niche in medical device.”

“We’re very happy to have that sort of support moving forward. I think it’s also great that a lot of our existing investors participated in in this round. It shows that they’re very supportive of the company,” he said.

Filed Under: Catheters, Featured, Funding Roundup, Hospital Care, Wall Street Beat Tagged With: accessvascular

More recent news

  • Neuralink files to raise $649M in new equity offering
  • BofA: Surgical robot remanufacturing not a major setback for Intuitive
  • InspireMD wins CE Mark approval for CGuard Prime
  • Philips reports first cases for VeriSight Pro 3D ICE catheter in Europe
  • Ceryx Medical raises $15M to support bioelectronic pacemaker

Primary Sidebar

“md
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest med device regulatory, business and technology news.

DeviceTalks Weekly

See More >

MEDTECH 100 Stock INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
MDO ad

Footer

MASSDEVICE MEDICAL NETWORK

DeviceTalks
Drug Delivery Business News
Medical Design & Outsourcing
Medical Tubing + Extrusion
Drug Discovery & Development
Pharmaceutical Processing World
MedTech 100 Index
R&D World
Medical Design Sourcing

DeviceTalks Webinars, Podcasts, & Discussions

Attend our Monthly Webinars
Listen to our Weekly Podcasts
Join our DeviceTalks Tuesdays Discussion

MASSDEVICE

Subscribe to MassDevice E-Newsletter
Advertise with us
About
Contact us

Copyright © 2025 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Privacy Policy